TL;DR
This PubMed entry refers to a 2001 comments piece that addresses potential differences between every-third-day and daily low‑dose aspirin regimens. The full article text is not available in the source, so specific findings and recommendations cannot be confirmed.
What happened
A PubMed record dated to 2001 carries a short comments item comparing the benefits of taking low‑dose aspirin every third day versus taking it daily. The database entry provides only the title and a brief excerpt labelled “Comments”; the underlying article text is not accessible from the source material supplied. Because the source lacks the full text and any abstracts or results, no conclusions, data, or recommendations from the original commentary can be verified. The record appears to be intended as an editorial or commentary rather than a primary randomized trial report, but authorship, the journal context, methodological details, and outcome data are not present in the available source. Coverage here is limited to the bibliographic reference; any clinical implications or comparative effectiveness claims are therefore unconfirmed in the source.
Why it matters
- Dosing frequency could influence both effectiveness and side‑effect profiles for aspirin regimens — not confirmed in the source.
- If less frequent dosing provided similar protection, it might affect adherence and prescribing patterns — not confirmed in the source.
- Understanding evidence behind alternative schedules is important for guideline development, but the source does not supply that evidence.
Key facts
- Source is a PubMed entry titled comparing every‑third‑day vs daily low‑dose aspirin therapy (2001).
- The item is categorized as a 'Comments' piece according to the supplied excerpt.
- Full article text was not available in the provided source material.
- PubMed identifier visible in the URL is 11190906.
- This report is based solely on the bibliographic record (title and short excerpt); no study data or conclusions are present in the source.
- Details such as authorship, journal name, and specific conclusions are not confirmed in the source.
What to watch next
- Whether the original commentary reported equivalent cardiovascular protection between every‑third‑day and daily low‑dose aspirin — not confirmed in the source.
- Any comparative safety signals (bleeding risk or other adverse events) attributed to dosing frequency — not confirmed in the source.
- Subsequent research or guideline statements that reference this 2001 comment and its claims — not confirmed in the source.
Quick glossary
- Low‑dose aspirin: A small daily dose of acetylsalicylic acid commonly used in cardiovascular prevention; exact dosing protocols vary by indication.
- Dosing regimen: The schedule and frequency at which a medication is taken (for example, daily versus every third day).
- Comments (journal): A short editorial or opinion piece in a medical journal that discusses or critiques research rather than presenting original trial data.
- PubMed ID (PMID): A unique identifier assigned to entries indexed in the PubMed database.
Reader FAQ
What did the 2001 article conclude about every‑third‑day versus daily low‑dose aspirin?
Not confirmed in the source.
Is every‑third‑day low‑dose aspirin recommended instead of daily dosing?
Not confirmed in the source.
Can I access the full text from the provided PubMed entry?
The supplied source indicates the full article text was not available; access details are not confirmed in the source.
Who authored the commentary and where was it published?
Not confirmed in the source.
Comments
Sources
- Comparing benefits of every-third-day vs. daily low-dose aspirin therapy (2001)
- A Comparison of Every-Third-Day Versus Daily Low-Dose …
- Comparative Effectiveness of Aspirin Dosing in …
Related posts
- The Suck Is Why We’re Here: On Writing, AI and Creative Work
- The Riven (1997) Diffs: Seeing Riven Differently Through Render Analysis
- Comparing benefits of every-third-day versus daily low-dose aspirin therapy